Ushbu ma'lumotlar faqat ta'lim maqsadida taqdim etilgan. U tibbiy maslahat sifatida mo'ljallanmagan. Har doim malakali tibbiyot mutaxassisiga murojaat qiling.
Tavsif, Dozalash, Nojo'ya ta'sirlar, Qarshi ko'rsatmalar. Data from EMA, URPL, openFDA and other regulatory sources.
| Ondansetron | Metoclopramide | |
|---|---|---|
| Faol moddalar | ONDANSETRON | METOCLOPRAMIDE HYDROCHLORIDE |
| ATC kodi | A04AA01 | A03FA01 |
| Dori shakli | — | INJECTABLE |
| Dozalash | — | EQ 5MG BASE/ML |
| Qo'llash usuli | — | INJECTION |
| Ishlab chiqaruvchi | JAMP PHARMA CORPORATION | AVET LIFESCIENCES LTD |
Ondansetron (INN: ONDANSETRON, ATC A04AA01) and Metoclopramide (INN: METOCLOPRAMIDE HYDROCHLORIDE, ATC A03FA01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ushbu ma'lumotlar faqat ta'lim maqsadida taqdim etilgan. U tibbiy maslahat sifatida mo'ljallanmagan. Har doim malakali tibbiyot mutaxassisiga murojaat qiling.